<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Vitale DL</submitter><funding>GLYCANC PROJECT - H2020</funding><pagination>246</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7914570</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(2)</volume><pubmed_abstract>UDP-glucose-dehydrogenase (UGDH) synthesizes UDP-glucuronic acid. It is involved in epirubicin detoxification and hyaluronan synthesis. This work aimed to evaluate the effect of UGDH knockdown on epirubicin response and hyaluronan metabolism in MDA-MB-231 breast cancer cells. Additionally, the aim was to determine UGDH as a possible prognosis marker in breast cancer. We studied UGDH expression in tumors and adjacent tissue from breast cancer patients. The prognostic value of UGDH was studied using a public Kaplan-Meier plotter. MDA-MB-231 cells were knocked-down for UGDH and treated with epirubicin. Epirubicin-accumulation and apoptosis were analyzed by flow cytometry. Hyaluronan-coated matrix and metabolism were determined. Autophagic-LC3-II was studied by Western blot and confocal micros</pubmed_abstract><journal>Biomolecules</journal><pubmed_title>Initial Identification of UDP-Glucose Dehydrogenase as a Prognostic Marker in Breast Cancer Patients, Which Facilitates Epirubicin Resistance and Regulates Hyaluronan Synthesis in MDA-MB-231 Cells.</pubmed_title><pmcid>PMC7914570</pmcid><funding_grant_id>645756</funding_grant_id><funding_grant_id>0561/2019</funding_grant_id><pubmed_authors>Vigetti D</pubmed_authors><pubmed_authors>Alaniz L</pubmed_authors><pubmed_authors>Parnigoni A</pubmed_authors><pubmed_authors>Caon I</pubmed_authors><pubmed_authors>Sevic I</pubmed_authors><pubmed_authors>Icardi A</pubmed_authors><pubmed_authors>Passi A</pubmed_authors><pubmed_authors>Spinelli FM</pubmed_authors><pubmed_authors>Vitale DL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Initial Identification of UDP-Glucose Dehydrogenase as a Prognostic Marker in Breast Cancer Patients, Which Facilitates Epirubicin Resistance and Regulates Hyaluronan Synthesis in MDA-MB-231 Cells.</name><description>UDP-glucose-dehydrogenase (UGDH) synthesizes UDP-glucuronic acid. It is involved in epirubicin detoxification and hyaluronan synthesis. This work aimed to evaluate the effect of UGDH knockdown on epirubicin response and hyaluronan metabolism in MDA-MB-231 breast cancer cells. Additionally, the aim was to determine UGDH as a possible prognosis marker in breast cancer. We studied UGDH expression in tumors and adjacent tissue from breast cancer patients. The prognostic value of UGDH was studied using a public Kaplan-Meier plotter. MDA-MB-231 cells were knocked-down for UGDH and treated with epirubicin. Epirubicin-accumulation and apoptosis were analyzed by flow cytometry. Hyaluronan-coated matrix and metabolism were determined. Autophagic-LC3-II was studied by Western blot and confocal micros</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Feb</publication><modification>2025-04-26T05:58:33.048Z</modification><creation>2021-03-03T08:09:56Z</creation></dates><accession>S-EPMC7914570</accession><cross_references><pubmed>33572239</pubmed><doi>10.3390/biom11020246</doi></cross_references></HashMap>